Hanall to launch Normix, a broad antibiotic.

Published: 2006-03-10 06:57:00

Updated: 2006-03-10 06:57:00

Hanall announced that Normix (Rifaximin) started to market from March 6 under the distribution agreement with Alfa Wassermann, an Italian pharmaceutical company dated on March 2. Normix tablet is an antibiotic specialized in the GI infections with which its pharmacological action limited only on ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK